##  [Partnering opportunities - Core Therapeutic Areas](/node/600066 "Partnering opportunities - Core Therapeutic Areas") 

  



We are looking for high-value, truly differentiating first or best-in-class treatments in:



 Cardiovascular, renal & metabolic (CRM)



  

#### Focus on areas of high unmet need, build on strong mid/late-stage pipeline

Atherosclerosis

- ASCVD prevention and treatment
- Novel mechanisms beyond LDL-C, Lp(a), HTN, and inflammation.

Heart Failure/Atrial Fibrillation

- Heart Failure with reduced or preserved ejection fraction
- Safer anti-arrhythmic therapies for Afib
- Cardiomyopathies, thrombosis, and hypertension

Metabolism/Obesity

- Novel mechanisms that complement SoC
- Better tolerability and weight loss maintenance

Nephrology

- Chronic Kidney Disease (Stage 3b/4)
- Glomerular diseases e.g. IgA Nephropathy (IgAN), Alport Syndrome

 ![Avi Spier](/sites/novartis_com/files/styles/crop_freeform/public/2025-09/avi-spier.jpg.webp?itok=9FoUGbbs "Avi Spier")

 



#### Avi Spier

[Contact](https://novartis.partneringplace.com/SubmissionUI/novartis/submission)









 

 

 



 



 Immunology



  

**Strong foundation and expect 6 Ph3 readouts, >10 Ph2 readouts in next 5 years Dermatology**

- Atopic Dermatitis
- Chronic Spontaneous Urticaria (CSU)
- Hidradenitis Suppurativa
- Lichen Planus
- Vitiligo

**Rheumatology**

- Lupus nephritis (LN)
- Sjogren's disease
- Spondyloarthropathies

Systemic Lupus Erythematosus (SLE)

**Inflammatory Bowel Disease**

- Crohn's Disease
- Ulcerative Colitis

**Exploratory Areas**

- B cell reset
- Food allergy
- Rheumatoid Arthritis

 ![Dominic Ehrismann portrait](/sites/novartis_com/files/styles/crop_freeform/public/2021-10/dominic-ehrismann-portrait.jpg.webp?itok=NIZkq8M0 "Dominic Ehrismann portrait")

 



#### Dominic Ehrismann

[Contact](https://novartis.partneringplace.com/SubmissionUI/novartis/submission)









 

 

 



 



 Neuroscience



  

**Focus on multiple sclerosis, neuromuscular and neurodegenerative diseases**

**Neurodegeneration**

- Parkinson’s Disease (PD)
- Alzheimer’s Disease
- Huntington’s Disease

**Neuromuscular**

- Amyotrophic lateral sclerosis (ALS)
- Larger neuro-muscular indications

**Multiple Sclerosis & Immuno-Neurology**

- Multiple Sclerosis (MS)
- Other neuroimmunology diseases (e.g., CIDP & MG)

 ![Chris Adams](/sites/novartis_com/files/styles/crop_freeform/public/2025-07/chris-adams.jpg.webp?itok=lpzEcWuJ "Chris Adams")

 



#### Christopher Adams

[Contact](https://novartis.partneringplace.com/SubmissionUI/novartis/submission)









 

 

 



 



 Oncology



  

**Focus areas on solid tumors, RLT and hematology**

**Solid Tumors**

- Breast cancers
- Prostate cancers
- Lung cancers
- Colorectal and pancreatic cancers

**Radioligand Therapy**

- Identify RLTs or PET imaging agents in solid tumor indications including novel isotopes, chelators, vectors, and targets

**Hematology**

- Non-Hodgkin lymphoma (NHL)
- Acute myeloid leukemia (AML) / Myelodysplastic syndrome (MDS)
- Non-malignant hematology, Myeloproliferative Neoplasms (MPN)

 ![Markus Werner](/sites/novartis_com/files/styles/crop_freeform/public/2023-10/markus-werne.jpg.webp?itok=QFdRZ5O7 "Markus Werner")

 



#### Markus Werner

[Contact](https://novartis.partneringplace.com/SubmissionUI/novartis/submission)









 

 

 



 



 

 





 



- [Print](/node/600066/printable/print)
- [PDF](/node/600066/printable/pdf)